Matinas BioPharma Holdings Inc (MTNB)
0.6344
-0.08
(-10.65%)
USD |
NYAM |
Nov 14, 16:00
0.6306
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Cash from Investing (Quarterly): -2.938M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.938M |
| March 31, 2024 | 2.00M |
| December 31, 2023 | 2.96M |
| September 30, 2023 | 1.084M |
| June 30, 2023 | 6.198M |
| March 31, 2023 | 3.00M |
| December 31, 2022 | -0.042M |
| September 30, 2022 | 5.75M |
| June 30, 2022 | -3.792M |
| March 31, 2022 | 2.961M |
| December 31, 2021 | 0.0567M |
| September 30, 2021 | 0.2427M |
| June 30, 2021 | 7.654M |
| March 31, 2021 | 8.817M |
| December 31, 2020 | 9.089M |
| September 30, 2020 | -2.780M |
| June 30, 2020 | 7.992M |
| March 31, 2020 | -54.97M |
| December 31, 2019 | -5.606M |
| September 30, 2019 | -0.0734M |
| June 30, 2019 | -0.3179M |
| March 31, 2019 | -0.0142M |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2018 | -0.2753M |
| June 30, 2018 | -0.1587M |
| March 31, 2018 | -0.1019M |
| December 31, 2017 | -0.1183M |
| September 30, 2017 | -0.0342M |
| June 30, 2017 | -0.7897M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | |
| December 31, 2015 | -0.0229M |
| September 30, 2015 | -0.0145M |
| June 30, 2015 | -0.0339M |
| March 31, 2015 | 0.0659M |
| December 31, 2014 | -0.00 |
| September 30, 2014 | -0.0307M |
| June 30, 2014 | -0.0645M |
| March 31, 2014 | -0.1933M |
| December 31, 2013 | -0.0659M |
| September 30, 2013 | -0.0283M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-54.97M
Minimum
Mar 2020
9.089M
Maximum
Dec 2020
-0.6485M
Average
2.00M
Median
Mar 2024
Cash from Investing (Quarterly) Benchmarks
| Equillium Inc | -1.351M |
| Tenon Medical Inc | 0.00 |
| Alphatec Holdings Inc | -19.88M |
| Merck & Co Inc | -3.845B |
| Madrigal Pharmaceuticals Inc | -202.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.106M |
| Cash from Financing (Quarterly) | 9.189M |
| Free Cash Flow | -17.87M |
| Free Cash Flow Per Share (Quarterly) | -0.6228 |
| Free Cash Flow Yield | -625.2% |